The FDA has granted emergency use authorization for the Aptima Zika virus assay system, from Hologic, for detection of the...
Luminex Corporation has received Emergency Use Authorization (EUA) from the FDA for a multiplex nucleic acid test called the xMAP...
Abbott announced that the U.S. FDA has authorised its molecular test, the Abbott RealTime ZIKA test, to detect Zika virus...
Grifols announced that the FDA approved the Procleix Zika Virus assay for the detection of the virus in individual or...
Innovation Pharmaceuticals announced that brilacidin, the Company’s defensin-mimetic drug candidate exhibiting broad-spectrum antiviral properties, is to be evaluated for its treatment potential against the monkeypox virus.
Respiratory syncytial virus (RSV) accounts for about 20% of all respiratory infections in children below the age of 5 y.
Hepatitis delta virus (HDV) is a defective virus that requires the hepatitis B virus (HBV) to complete its life cycle in human hepatocytes. HDV virions contain an envelope incorporating HBV surface antigen protein and a ribonucleoprotein...
Introduction: The REGAL (RSV Evidence - A Geographical Archive of the Literature) series has provided a comprehensive review of the published evidence in the field of respiratory syncytial virus (RSV) in Western countries over the last 20 years.
Background: Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infection globally. There are vaccine candidates in development, but a systematic review on immunogenicity and safety of vaccine is lacking.
This meta-analysis aims to present a collective view on the relationship between viral infection and IPF.